Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Clinical Case Reports|June 10, 2022
Orbital inflammatory disease following mRNA SARS-CoV-2 vaccineSolange Grunenwald, Gabriel Lethellier, Philippe Imbert, et al.
Pituitary|November 8, 2011
Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotideElisabeth Couture, Vanina Bongard, Jean-Christophe Maiza, et al.
Endocrine|August 1, 2020
First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegalyMagaly Vialon, Solange Grunenwald, Céline Mouly, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 11, 2009
Ectopic Cushing's syndrome due to a pheochromocytoma: a new case in the post-partum and review of literatureClémentine Cohade, Stéphanie Broussaud, Estelle Louiset, et al.
Clinical Endocrinology|March 1, 2019
Medical therapy in patients with endogenous hypoglycaemia: Is euglycaemia achievable?Delphine Vezzosi, Eric Guillaume, Antoine Bennet, et al.
Investigative Ophthalmology & Visual Science|March 23, 2013
Ocular inflammation and corneal permeability alteration by benzalkonium chloride in rats: a protective effect of a myosin light chain kinase inhibitorMarie Thérèse Droy-Lefaix, Lionel Bueno, Philippe Caron, et al.
European Thyroid Journal|March 30, 2018
Severe Inflammatory Ophthalmopathy in a Euthyroid Patient during Nivolumab TreatmentPauline Campredon, Philippe Imbert, Céline Mouly, et al.
Clinical Endocrinology|May 22, 2020
New variant (Val597Ile) in transmembrane region of the TSH receptor with human chorionic gonadotropin hypersensitivity in familial gestational hyperthyroidismPhilippe Caron, Stéphanie Broussaud, Juan José Galano-Frutos, et al.
Pituitary|January 12, 2011
Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotideJean-Christophe Maiza, Stéphane Castillo-Ros, Maria Matta, et al.
Clinical Endocrinology|January 25, 2006
Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegalyPhilippe Caron, Muriel Cogne, Isabelle Raingeard, et al.
Pageof 16